Establishes pharmacist licensing exemption for certain dialysis-related drugs and devices.
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed General Assembly
- Passed Senate
- To Governor
- Became Law
Overview
This bill creates an exception to New Jersey’s pharmacist licensing requirements for certain drugs and devices used in home dialysis for patients with end-stage renal disease. Specifically, it allows manufacturers and wholesalers to sell these dialysis-related products without requiring a pharmacist to be present, provided they meet specific criteria related to FDA approval, proper registration, original packaging, physician orders, and quality assurance assessments by a registered consultant pharmacist.
Bill text
Read the latest version inline or switch to a previous version.
Document of record
- Version
- Third Reading Reprint
- Published
- Not published in the source record
This version is published only as a document. Open the viewer to read it here, or download the file.
Sponsors
Official sponsors from legislative records.
3 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours